Changes in allogenic HSCT rates from 1990 to 2000 in 9 selected countries with predictions for 2003
| . | Year of transplantation . | Maximum transplantation rate . | Predictions 2003 . | ||||
|---|---|---|---|---|---|---|---|
| 1990 . | 1995 . | 2000 . | Year . | Transplantation rate . | Transplantation rate . | r2 . | |
| Leukemias | |||||||
| Acute myeloid leukemia | 13.2 ± 2.2 | 22.4 ± 3.2 | 37.7 ± 4.1 | 2000 | — | 49 | 0.997 |
| Acute lymphocytic leukemia | 12.7 ± 2.8 | 21.0 ± 2.5 | 26.9 ± 3.3 | 2000 | — | 32 | 0.975 |
| Chronic myeloid leukemia | 14.4 ± 2.1 | 20.3 ± 3.1 | 28.3 ± 4.6 | 1999 | 30.7 ± 3.7 | (36)3-150 | 0.925 |
| Myelodysplastic syndromes | 2.2 ± 1.9 | 6.3 ± 1.2 | 10.5 ± 1.2 | 2000 | — | 14 | 0.986 |
| Chronic lymphocytic leukemia | 0.4 ± 0.2 | 0.7 ± 0.5 | 2.9 ± 0.8 | 2000 | — | 5 | 0.951 |
| Lymphoproliferative disorders | |||||||
| Multiple myeloma | 1.4 ± 1.0 | 2.7 ± 1.2 | 7.4 ± 1.5 | 2000 | — | 11 | 0.971 |
| Hodgkin disease | 0.6 ± 0.3 | 0.4 ± 0.2 | 1.7 ± 0.5 | 2000 | — | 3 | 0.901 |
| Non-Hodgkin lymphoma | 2.2 ± 0.8 | 4.7 ± 1.5 | 10.7 ± 1.8 | 2000 | — | 16 | 0.985 |
| Nonmalignant disorders | |||||||
| Aplastic anemia + Fanconi | 4.0 ± 1.0 | 4.8 ± 1.3 | 5.7 ± 0.5 | 2000 | — | 5.3 | 0.530 |
| Combined immune deficiencies | 0.8 ± 0.5 | 1.3 ± 0.5 | 2.2 ± 0.6 | 2000 | — | 2.5 | 0.892 |
| Inborn errors | 0.9 ± 0.7 | 2.2 ± 0.6 | 3.4 ± 0.6 | 1999 | 3.8 ± 0.6 | 4.5 | 0.868 |
| . | Year of transplantation . | Maximum transplantation rate . | Predictions 2003 . | ||||
|---|---|---|---|---|---|---|---|
| 1990 . | 1995 . | 2000 . | Year . | Transplantation rate . | Transplantation rate . | r2 . | |
| Leukemias | |||||||
| Acute myeloid leukemia | 13.2 ± 2.2 | 22.4 ± 3.2 | 37.7 ± 4.1 | 2000 | — | 49 | 0.997 |
| Acute lymphocytic leukemia | 12.7 ± 2.8 | 21.0 ± 2.5 | 26.9 ± 3.3 | 2000 | — | 32 | 0.975 |
| Chronic myeloid leukemia | 14.4 ± 2.1 | 20.3 ± 3.1 | 28.3 ± 4.6 | 1999 | 30.7 ± 3.7 | (36)3-150 | 0.925 |
| Myelodysplastic syndromes | 2.2 ± 1.9 | 6.3 ± 1.2 | 10.5 ± 1.2 | 2000 | — | 14 | 0.986 |
| Chronic lymphocytic leukemia | 0.4 ± 0.2 | 0.7 ± 0.5 | 2.9 ± 0.8 | 2000 | — | 5 | 0.951 |
| Lymphoproliferative disorders | |||||||
| Multiple myeloma | 1.4 ± 1.0 | 2.7 ± 1.2 | 7.4 ± 1.5 | 2000 | — | 11 | 0.971 |
| Hodgkin disease | 0.6 ± 0.3 | 0.4 ± 0.2 | 1.7 ± 0.5 | 2000 | — | 3 | 0.901 |
| Non-Hodgkin lymphoma | 2.2 ± 0.8 | 4.7 ± 1.5 | 10.7 ± 1.8 | 2000 | — | 16 | 0.985 |
| Nonmalignant disorders | |||||||
| Aplastic anemia + Fanconi | 4.0 ± 1.0 | 4.8 ± 1.3 | 5.7 ± 0.5 | 2000 | — | 5.3 | 0.530 |
| Combined immune deficiencies | 0.8 ± 0.5 | 1.3 ± 0.5 | 2.2 ± 0.6 | 2000 | — | 2.5 | 0.892 |
| Inborn errors | 0.9 ± 0.7 | 2.2 ± 0.6 | 3.4 ± 0.6 | 1999 | 3.8 ± 0.6 | 4.5 | 0.868 |
Numbers reflect weighted transplantation rates per 10 million inhabitants.
indicates limitations of mathematical model; see “Results.”